FDA approves first drug for spinal muscular atrophy

SILVER SPRING, Md., Dec. 23, 2016 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle...